Akademisyen
YILMAZ ÇAPAN
PROFESÖR
LOKMAN HEKİM ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK TEKNOLOJİSİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Teknoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 108
- Proje 8
- Kitap 6
- Bildiri 41
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
18
Q2
17
Q3
9
Q4
1
WoS (JCR)
Q1
13
Q2
11
Q3
5
Q4
13
TR Index
2
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
73.4%
Üst %1 payı
0.0%
Üst %10 payı
14.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2021 Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.6%
- 2021 Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.9%
- 2020 Brain-targeted nanoparticles to overcome the blood-brain barrier YÖKSİS
- 2019 Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX‐G3 in healthy and neutropenia‐induced rats YÖKSİS SJR Q3 JCR Q4
- 2019 Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.9%
- 2019 Synthesis of Small-Sized Mesoporous Silica Nanoparticles by Experimental Design and Characterization for Further Drug Delivery YÖKSİS SJR Q3 JCR Q4 OpenAlex 76.9%
- 2019 Development and validation of stability-indicating HPLC method for diflucortolone valerate and isoconazole nitrate combination YÖKSİS SJR Q3 JCR Q4
- 2019 Development of Paclitaxel and Flurbiprofen Co-Loaded PLGA Nanoparticles: Understanding Critical Formulation and Process Parameters Using Plackett–Burman Design YÖKSİS TR Index OpenAlex 42.1%
- 2019 Development of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett– Burman design YÖKSİS TR Index OpenAlex 42.1%
- 2018 Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles YÖKSİS SJR Q2 JCR Q2 OpenAlex 68.9%
- 2018 Characterization of bevacizumab by dynamic light scattering while maintaining its native structure. YÖKSİS SJR Q2 JCR Q4
- 2018 Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles YÖKSİS SJR Q2 JCR Q2
- 2018 Characterization of bevacizumab by dynamic light scattering while maintaining its native structure YÖKSİS SJR Q2 JCR Q4
- 2017 DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODSUSED FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITYAND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTANCILEXETIL 32 MG TABLETS YÖKSİS SJR Q2 JCR Q4
- 2017 Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC). YÖKSİS SJR Q2 JCR Q4
- 2017 Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles. YÖKSİS SJR Q2 JCR Q4
- 2017 Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.7%
- 2017 Using PVA and TPGS as combined emulsifier in nanorecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles YÖKSİS SJR Q2 JCR Q4
- 2017 A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles characteristics and efficacy of intracellular delivery YÖKSİS SJR Q2 JCR Q2
- 2016 Preformulation of Immediate Release Candesartan Cilexetil Tablets Using Full Factorial Experimental Design YÖKSİS SJR Q3 JCR Q4